222 related articles for article (PubMed ID: 19637140)
1. [Toxoplasmosis after immunosuppressive therapy--our experience].
Rusináková Z; Raida L; Faber E; Tomková J; Bednaríková J; Indrák K; Novotný D
Klin Mikrobiol Infekc Lek; 2009 Jun; 15(3):95-8. PubMed ID: 19637140
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasmosis after hematopoietic stem cell transplantation.
Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy.
Duband S; Cornillon J; Tavernier E; Dumollard JM; Guyotat D; Péoc'h M
Transpl Infect Dis; 2008 Oct; 10(5):372-4. PubMed ID: 18384483
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.
Roemer E; Blau IW; Basara N; Kiehl MG; Bischoff M; Günzelmann S; Kirsten D; Sanchez H; Wocker EL; Fauser AA
Clin Infect Dis; 2001 Jan; 32(1):E1-8. PubMed ID: 11118397
[TBL] [Abstract][Full Text] [Related]
5. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
6. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques.
Fricker-Hidalgo H; Bulabois CE; Brenier-Pinchart MP; Hamidfar R; Garban F; Brion JP; Timsit JF; Cahn JY; Pelloux H
Clin Infect Dis; 2009 Jan; 48(2):e9-e15. PubMed ID: 19072243
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B
APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
Busemann C; Ribback S; Zimmermann K; Sailer V; Kiefer T; Schmidt CA; Schulz K; Steinmetz I; Dombrowski F; Dölken G; Krüger WH
Ann Hematol; 2012 Jul; 91(7):1081-9. PubMed ID: 22249208
[TBL] [Abstract][Full Text] [Related]
10. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
[TBL] [Abstract][Full Text] [Related]
11. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation.
Amir G; Salant H; Resnick IB; Karplus R
J Am Acad Dermatol; 2008 Nov; 59(5):781-4. PubMed ID: 18723241
[TBL] [Abstract][Full Text] [Related]
13. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
14. Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation.
Machado M; Moreb JS; Khan SA
Bone Marrow Transplant; 2007 Nov; 40(10):979-82. PubMed ID: 17846605
[TBL] [Abstract][Full Text] [Related]
15. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
16. Determining Toxoplasma high-risk autologous and allogeneic hematopoietic stem cell transplantation patients by systematic pre-transplant PCR screening of stem cell originated buffy coat.
Caner A; Dönmez A; Döşkaya M; Değirmenci A; Tombuloğlu M; Cağirgan S; Guy E; Francis J; Soyer NA; Gürüz Y
Parasitol Int; 2012 Dec; 61(4):565-71. PubMed ID: 22609887
[TBL] [Abstract][Full Text] [Related]
17. Prevention of toxoplasmosis in transplant patients.
Derouin F; Pelloux H;
Clin Microbiol Infect; 2008 Dec; 14(12):1089-101. PubMed ID: 19018809
[TBL] [Abstract][Full Text] [Related]
18. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
[TBL] [Abstract][Full Text] [Related]
19. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
20. [Current options for the diagnosis and therapy of toxoplasmosis in HIV-negative patients].
Prásil P
Klin Mikrobiol Infekc Lek; 2009 Jun; 15(3):83-90. PubMed ID: 19637138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
